524 related articles for article (PubMed ID: 15117925)
21. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
[TBL] [Abstract][Full Text] [Related]
22. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
23. Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06.
Livermore DM; Hope R; Brick G; Lillie M; Reynolds R;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii41-54. PubMed ID: 18819979
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013.
Jean SS; Coombs G; Ling T; Balaji V; Rodrigues C; Mikamo H; Kim MJ; Rajasekaram DG; Mendoza M; Tan TY; Kiratisin P; Ni Y; Weinman B; Xu Y; Hsueh PR
Int J Antimicrob Agents; 2016 Apr; 47(4):328-34. PubMed ID: 27005459
[TBL] [Abstract][Full Text] [Related]
25. Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins.
Betriu C; Salso S; Sánchez A; Culebras E; Gómez M; Rodríguez-Avial I; Picazo JJ
Int J Antimicrob Agents; 2006 Jul; 28(1):1-5. PubMed ID: 16769202
[TBL] [Abstract][Full Text] [Related]
26. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
27. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
[TBL] [Abstract][Full Text] [Related]
28. Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs.
Spanu T; Luzzaro F; Perilli M; Amicosante G; Toniolo A; Fadda G;
Antimicrob Agents Chemother; 2002 Jan; 46(1):196-202. PubMed ID: 11751134
[TBL] [Abstract][Full Text] [Related]
29. Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms.
Mody RM; Erwin DP; Summers AM; Carrero HA; Selby EB; Ewell AJ; Moran KA
Ann Clin Microbiol Antimicrob; 2007 Jun; 6():6. PubMed ID: 17553151
[TBL] [Abstract][Full Text] [Related]
30. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
Akyar I
Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
[TBL] [Abstract][Full Text] [Related]
31. Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.
Livermore DM; Oakton KJ; Carter MW; Warner M
Antimicrob Agents Chemother; 2001 Oct; 45(10):2831-7. PubMed ID: 11557477
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011.
Hawser SP; Badal RE; Bouchillon SK; Hoban DJ; Hackel MA; Biedenbach DJ; Goff DA
J Infect; 2014 Jan; 68(1):71-6. PubMed ID: 24016768
[TBL] [Abstract][Full Text] [Related]
33. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
[TBL] [Abstract][Full Text] [Related]
34. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
[TBL] [Abstract][Full Text] [Related]
35. Comparative in-vitro activities of ertapenem against aerobic bacterial pathogens isolated from patients with complicated intra-abdominal infections.
Pelak BA; Woods GL; Teppler H; Friedland I; Bartizal K; Motyl M
J Chemother; 2002 Jun; 14(3):227-33. PubMed ID: 12120874
[TBL] [Abstract][Full Text] [Related]
36. Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.
Al-Zarouni M; Senok A; Al-Zarooni N; Al-Nassay F; Panigrahi D
Med Princ Pract; 2012; 21(6):543-7. PubMed ID: 22722224
[TBL] [Abstract][Full Text] [Related]
37. Resistance in gram-negative bacteria: enterobacteriaceae.
Paterson DL
Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009).
Hawser SP; Bouchillon SK; Lascols C; Hackel M; Hoban DJ; Badal RE; Cantón R
Clin Microbiol Infect; 2012 Mar; 18(3):253-9. PubMed ID: 21635662
[TBL] [Abstract][Full Text] [Related]
39. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Nijssen S; Florijn A; Bonten MJ; Schmitz FJ; Verhoef J; Fluit AC
Int J Antimicrob Agents; 2004 Dec; 24(6):585-91. PubMed ID: 15555882
[TBL] [Abstract][Full Text] [Related]
40. Activity of faropenem against cephalosporin-resistant Enterobacteriaceae.
Mushtaq S; Hope R; Warner M; Livermore DM
J Antimicrob Chemother; 2007 May; 59(5):1025-30. PubMed ID: 17353220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
